Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Regulated differentiation of stem cells into an artificial 3D liver as a transplantable source

Feng Chen, Hua Wang, Jia Xiao

Clin Mol Hepatol. 2020;26(2):163-179. Published online February 27, 2020

DOI: https://doi.org/10.3350/cmh.2019.0022n

View: 11012 Download: 282 Web of Science: 5 Crossref: 4

Original Article

Clinicopathologic significance of the expression of Snail in hepatocellular carcinoma

Hyun Young Woo, Ae Lyoung Min, Jong Young Choi, Si Hyun Bae, Seung Kew Yoon, Chan Kwon Jung

Clin Mol Hepatol. 2011;17(1):12-18. Published online March 21, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.1.12

View: 8601 Download: 55 Crossref: 13

2

Clinical application of stem cells in Liver diseases

Si Hyun Bae

Clin Mol Hepatol. 2008;14(3):309-317. Published online September 30, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.3.309

View: 7057 Download: 99 Crossref: 10

Problems and Prospects of Stem Cells for Clinical Use in Hepatology

Si Hyun Bae

Clin Mol Hepatol. 2005;11(2):106-115. Published online January 1, 1970

View: 2344 Download: 12

3

In vitro Induction of Cellular Differentiation of Human Fetal Liver Cell Lines with Sodium Butyrate

Jung Hwan Yoon , June Sung Lee , Hyo Suk Lee , Chung Yong Kim

Clin Mol Hepatol. 1997;3(3):193-201. Published online January 1, 1970

View: 2334 Download: 14

Original Article

Molecular Classification of Hepatocellular Carcinoma based on Zoned Metabolic Feature and Oncogenic Signaling Pathway

Tomoko Aoki, Naoshi Nishida, Yutaka Kurebayashi, Kazuko Sakai, Naoto Fujiwara, Masakatsu Tsurusaki, Kohei Hanaoka, Masahiro Morita, Hirokazu Chishina, Masahiro Takita, Satoru Hagiwara, Hiroshi Ida, Kazuomi Ueshima, Yasunori Minami, Atsushi Takebe, Takaaki Murase, Keiko Kamei, Takuya Nakai, Ippei Matsumoto, Kazuto Nishio, Masatoshi Kudo

Received December 3, 2024 Accepted March 7, 2025

DOI: https://doi.org/10.3350/cmh.2024.1088 [Accepted]

View: 601 Download: 71

1 |

Viewed By 7362	MAFLD: How is it different from NAFLD?
Viewed By 6913	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 5569	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 5339	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4766	Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease

Cited By 298	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 270	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 186	MAFLD: How is it different from NAFLD?
Cited By 93	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 92	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search